Basic helix-loop-helix (bHLH) transcription factors play a pivotal role in the regulation of tumorigenesis, and also in a wide range of other developmental processes in diverse species from yeast to humans. Here we demonstrate for the first time that Ret finger protein (RFP), a member of the TRIM family of proteins initially identified as a recombined transforming gene from a human lymphoma, is a novel interaction partner for four different bHLH proteins (SCL, E47, MyoD and mASH-1), but does not interact with GATA-1 or PU.1. Interaction with SCL required the B-box and first coiled-coil region of RFP together with the bHLH domain of SCL. RFP was able to repress transcriptional activation by E47, MyoD and mASH-1, but not by members of several other transcription factor families. Transcriptional repression by RFP was trichostatin A sensitive and did not involve an Id-like mechanism or ubiquitination with subsequent degradation of bHLH proteins. Instead, our results suggest that bHLH transcription factors are regulated by a previously undescribed interaction with RFP, which functions to recruit HDAC and/or Polycomb proteins and thus repress target genes of bHLH proteins. These results reveal an unexpected link between the bHLH and TRIM protein families.
Introduction
Transcription factors of the basic helix-loop-helix (bHLH) family have been implicated in the pathogenesis of several tumours (Look, 1997; Massari and Murre, 2000; Sikder et al., 2003) and act as critical regulators of many eukaryotic developmental processes including differentiation, cellular proliferation and sex determination (Massari and Murre, 2000) . The conserved HLH region mediates homo-and hetero-dimerization and an additional conserved basic domain that may be present adjacent to the HLH region mediates DNA binding (Massari and Murre, 2000) . All tissue-specific bHLH proteins interact with ubiquitously expressed E proteins to form heterodimers that bind to an E-box (CANNTG) motif. The function of bHLH proteins may be modulated by complex formation with other bHLH or non-bHLH proteins (Massari and Murre, 2000) .
The Stem Cell Leukaemia (SCL) gene, also known as Tal-1, encodes a bHLH transcription factor which functions as a critical regulator of both haematopoietic and endothelial development . Targeted mutation of the SCL gene has demonstrated that SCL is important for the genesis but not the maintenance of haematopoietic stem cells (HSCs) (Hall et al., 2003; Mikkola et al., 2003) . SCL was first identified by virtue of its ectopic expression in T-cell acute lymphoblastic leukaemia (T-ALL) and overexpression of SCL is now recognized as one of the most common molecular abnormalities found in human T-ALL (Begley and Green, 1999) . Recent data suggest that SCL promotes leukaemogenesis by inhibiting the activity of class I bHLH factors of the E2A family (O'Neill et al., 2004) .
Ret finger protein (RFP) was first identified in transformed mouse fibroblasts as the N-terminal half of an RFP/ret fusion protein, following transfection of genomic DNA from a human lymphoma (Takahashi and Cooper, 1987) . RFP belongs to an expanding family of RBCC (also called TRIM) proteins containing a tripartite motif comprising RING and B-box zincfingers and a variable coiled-coil domain (reviewed in Reymond et al., 2001) . Other proteins of the TRIM family also exert oncogenic potential when recombined, for example TIF-1 (Klugbauer and Rabes, 1999) and PML (Borrow et al., 1990; Chang et al., 1992) . RFP is reported to be widely expressed and, depending on the cell type, RFP may be localized to the nucleus or cytoplasm (Tezel et al., 1999) . In the nucleus RFP is a component of PML nuclear bodies and binds directly to PML (Cao et al., 1998) . RFP has also been shown to interact with int-6, another component of PML nuclear bodies (Morris-Desbois et al., 1999) , and with Enhancer of Polycomb (Shimono et al., 2000) . It has been suggested that RFP contains one or more repression domains (Shimono et al., 2000) , but the biological function(s) of RFP remain obscure.
In order to further illuminate the mechanisms whereby SCL produces its cell-specific functions, we have searched for additional SCL-interacting proteins. Here we demonstrate that RFP is a novel interaction partner for SCL and also binds several other bHLH proteins. Moreover, our data show that RFP functions to repress transcriptional activation by bHLH proteins but not members of other transcription factor families, and therefore reveal a previously unrecognized link between the bHLH and TRIM protein families.
Results

RFP interacts with SCL in mammalian cells
To identify potential SCL-interacting proteins, a yeast two-hybrid strategy was employed using a full-length GAL4BD-SCL fusion protein to screen an E10.5 whole mouse embryo cDNA library. Three of the interacting clones contained an identical N-terminal fragment of RFP (amino acids . No interaction was observed between GAL4AD-RFP (35-174) and either GAL4BD alone, GAL4BD-Nef or GAL4BD-TNF death domain, suggesting a specific interaction between RFP and SCL (data not shown). Several lines of evidence suggested that the interaction with RFP might have physiological significance and should be considered in further detail. RT-PCR analysis of a panel of 16 adult and embryonic mouse tissues and Northern analysis of 29 murine haematopoietic cell lines demonstrated that RFP was expressed in every sample tested and therefore coexpressed with SCL in multiple cell types (data not shown). Moreover, it has been reported that RFP is expressed in the nucleus of many cell types (Tezel et al., 1999) .
GST pulldown experiments using 35 S-labelled SCL and bacterially expressed GST-RFP confirmed the interaction between SCL and RFP (data not shown). Subsequently, immunoprecipitation of COS-7 cells transfected with plasmids encoding flag tagged RFP and/or myc tagged SCL showed that RFP co-immunoprecipitated with SCL (Figure 1a ), thus demonstrating that the two proteins can interact in mammalian cells. In addition, interaction of the endogenous proteins in the haematopoietic progenitor cell line 416B was demonstrated by co-immunoprecipitation of RFP and SCL (Figure 1b) . Two bands corresponding to RFP were observed in the cell lysate, suggesting either the existence of alternative RNA splice forms or that a proportion of RFP is post-translationally modified. Interestingly, only one of the bands was observed to interact with SCL.
The interaction is mediated by the bHLH domain of SCL and the B-box and first coiled-coil of RFP To specify the region of RFP that interacts with SCL, a series of RFP deletion constructs fused in-frame with the GAL4AD were generated, and their ability to interact with GAL4BD-SCL was tested using a yeast two-hybrid system. Expression of the fusion proteins was confirmed by Western blotting of transformed yeast (data not shown), and interaction was defined by auxotrophy to leucine, tryptophan and histidine, together with a positive LacZ assay (Figure 2a ). Full-length RFP did not give a positive result using this assay, but there are several possible explanations for apparent noninteraction in a yeast two-hybrid system, including steric constraints in the context of a fusion protein or the presence of a transcription repression domain (Shimono et al., 2000) . Consistent with the latter interpretation, deletion of a C-terminal 355 amino-acid fragment of RFP resulted in restoration of a positive yeast twohybrid result. Further deletions demonstrated that the B-box and first coiled-coil motif (amino acids 81-158) were necessary and sufficient for the interaction with SCL ( Figure 2b ).
GST pulldown assays were also performed to characterize the region of SCL that interacts with RFP. SCL deletion constructs were fused in-frame with GST and appropriate expression of the fusion proteins was checked in bacterial lysates (data not shown). The fusion proteins were then tested for their ability to interact with full-length in vitro translated radiolabelled RFP ( Figure 2c ). As shown in Figure 2d , a fragment containing the bHLH domain of SCL was shown to be both necessary and sufficient for the interaction with RFP. 
RFP specifically inhibits transactivation by bHLH transcription factors
We next sought to determine whether RFP influences transcriptional regulation by SCL. For this purpose, transient luciferase reporter assays were performed in 416B cells (Figure 3a) . Consistent with previous observations (Hsu et al., 1994) , E47 alone strongly transactivated a reporter containing six copies of the E2A/SCL consensus binding site (E6pXp2). Transfection of E47 plus SCL resulted in more modest transactivation, whereas transfection of SCL alone did not result in significant transactivation. Addition of RFP significantly repressed transactivation by both E47 and E47/SCL (Figure 3a) . The striking repression of E47 alone raised the possibility that RFP might inhibit E47 directly and that the observed effects did not require the presence of SCL, but interpretation of these results was complicated by the fact that 416B cells express endogenous SCL. Therefore, the transactivation experiments were repeated in WEHI 3BD þ cells, which do not express SCL (Tanigawa et al., 1994) , and essentially identical results were obtained ( Figure 3b ). These results demonstrate that RFP does not need SCL to repress E47. Since SCL alone was unable to transactivate the reporter, which is in agreement with previous reports (Hsu et al., 1991) , the effect of RFP on SCL could not be assessed.
Further GST pulldown experiments confirmed that RFP was indeed able to bind E47 and that the interaction was mediated via the bHLH domain ( Figure 4a , top two panels). Moreover, RFP was able to bind two other bHLH proteins, MyoD and mASH-1, but not the zinc-finger transcription factor GATA-1 or the Ets family transcription factor PU.1 (Figure 4a ).
Repression of E47 by RFP required the presence of the B-box and the first coiled-coil of RFP (Figure 4b ), consistent with our observation that these domains were sufficient for the interaction with SCL ( Figure 2b ).
In order to investigate the functional significance of these interactions, additional luciferase reporter assays a) Expression of RFP inhibits transactivation by SCL/ E47 and E47 alone in 416B cells. Activity of the reporter transfected with E47 alone was set to 100 and the remainder of the data were calculated relative to this. (b) Inhibition of transactivation does not require the presence of SCL. The experiment described in (a) was repeated in Wehi 3BD þ cells, which do not express SCL were established in 416B cells using several different transcription factor expression vectors and appropriate reporter plasmids. As shown in Figure 4c , RFP repressed the activity of mASH-1 alone, mASH-1 with E47, MyoD alone and MyoD with E47 from promoters with multimerized E-boxes, as well as from physiological regulatory elements. By contrast, RFP was unable to inhibit transactivation by representatives of several other classes of transactivators, including HoxD4 (homeobox), GATA-1 (zinc-finger), PU.1 (Ets domain) and VP16 (acidic).
Taken together, these data demonstrate that RFP did not repress members of several transcription factor families, but did inhibit the transcriptional activity of four different bHLH proteins
RFP inhibits bHLH transactivation by acting as a transcriptional repressor
Several mechanisms may be responsible for the inhibition of bHLH protein function by RFP. Firstly, many RING-finger proteins function as E3 ubiquitin ligases and by ubiquitination of partner proteins target them for proteosomal degradation (Jackson et al., 2000) . To investigate the possibility that RFP promotes the degradation of SCL or E47, we assessed transactivation of an E-box-driven luciferase construct by SCL and E47 in the presence or absence of RFP, and measured protein levels of SCL and E47 at the same time. Consistent with our results in 416B cells, RFP inhibited transactivation by SCL and E47 in 293T cells (Figure 5a ). Western blot analysis showed that levels of E47 and myc-SCL were not reduced in the presence of RFP (Figure 5b ), thus demonstrating that RFP does not inhibit the function of bHLH proteins by promoting their degradation.
Secondly, RFP may be exerting its inhibitory effects by preventing bHLH proteins from binding DNA. To investigate this, nuclear extracts were prepared from 416B cells and a gel shift assay was performed. As shown in Figure 5c , the addition of flag-RFP to the binding reaction did not change the intensity of the E47-mycSCL band or result in the formation of a new low mobility complex (Figure 5c, lane 8) . Moreover, no bands were supershifted with the addition of an anti-flag antibody to the binding reaction (Figure 5c, lane 12) . A Western blot verified the expression of RFP (data not shown) and the experiment was also performed in COS cells with similar results (data not shown). Gel shift assays performed with in vitro translated proteins also showed that RFP did not interfere with the DNA binding of E47-E47 homodimers (data not shown). Taken together, these data demonstrate that RFP did not interfere with the binding of bHLH proteins to their DNA-binding sites. Our inability to detect a low mobility complex containing RFP, E47 and SCL is likely to reflect the relatively low sensitivity of gel shift assays compared to GST pulldowns as a way of detecting protein-protein interactions.
Thirdly, RFP might function in a manner analogous to Id proteins, which inhibit other bHLH factors by The interaction domain of RFP (B-box and first coiled-coil) is necessary for the inhibition of transcriptional transactivation by E47. Transfections and luciferase assays were performed as described in the Materials and methods in 293T cells. A full-length RFP was able to inhibit transcriptional transactivation of an E-box-driven luciferase by E47, whereas a truncated RFP missing the B-box and first coiledcoil (RFPdBC) was not. Expression of the two proteins was confirmed by Western blot (data not shown). (c) Expression of RFP inhibits transactivation of MyoD and mASH-1 alone or in combination with E47, but has no effect on transactivation mediated by the non-bHLH proteins. E6pXp2 is an artificial reporter containing six E boxes bound by E47 and EB7Luc contains a multimerized E box from the NeuroD2 promoter that can be bound by mASH-1 and NeuroD1 in vivo (Farah et al., 2000) . TnILuc contains part of the Quail Troponin I enhancer including a MyoD-binding site. 4PU1-tkLuc and pHDLuc contain multimerized PU.1 or GAL4 DNA-binding sites, respectively, pSX contains part of the HoxD4 enhancer responsive to HoxD4, and pGL2-21a contains SCL promoter 1a, which includes a GATAbinding site. In order to account for differences in luciferase activity between different luciferase reporter plasmids and different transactivating transcription factors, absolute luciferase activities were normalized so that the relevant luciferase activity for each different sample in the absence of RFP was 100 forming biologically inactive heterodimers (Yokota and Mori, 2002) . However, as shown in Figure 5d , RFP was able to inhibit transactivation by both E47 and a tethered E47BMyoD known to be resistant to negative regulation by Id proteins (Neuhold and Wold, 1993) . These data indicate that RFP does not act in the same way as Id proteins.
Lastly, we investigated whether RFP was able to inhibit bHLH transactivation by acting as a transcriptional repressor. RFP fragments were therefore fused to the GAL4BD and were transfected into 416B cells with a GAL4-luciferase reporter. Fusion constructs containing full-length RFP (amino acids 1-513) or a C-terminal region containing the distal coiled coils and the For each sample, luciferase activity was measured to verify the inhibitory effect of RFP (a) and levels of SCL, E47 and RFP expression were assessed by Western blotting (b). An anti-actin antibody was also used to account for variations in loading. (c) RFP does not prevent bHLH proteins from binding DNA. Nuclear extracts (NE) were prepared from 416B cells transiently transfected with plasmids for myc-SCL, E47 with (NE þ E/S/R) or without (NE þ E/S) flag-RFP as indicated. The oligo sequence used was: CCTGCAGCAGCTGGCAG GAA and it was 32 P labelled as indicated. Protein-DNA complexes were resolved using nondenaturing PAGE and the bound oligonucleotides were detected by autoradiography. (d) RFP does not interfere with dimerization of bHLH proteins. 416B cells were cotransfected with expression plasmids for E47 and MyoD or a tethered MyoD-E47 construct and RFP as indicated, together with E6pXp2 luciferase reporter. (e) RFP has both N-and C-terminal repression domains. A series of RFP deletions fused in-frame to the GAL4BD were transfected into 416B cells together with a luciferase reporter linked to a multimerized GAL4 DNA-binding site and a minimal promoter (pHDLuc) and luciferase activity was measured. (f) RFP-mediated repression of E47, MyoD and mASH-1 is relieved by the addition of trichostatin A (TSA). 416B cells were cotransfected with expression plasmids for E47, MyoD and mASH-1 with or without RFP as indicated, in addition to the E6pXp2 (for E47, MyoD) or the EB7Luc (for mASH-1) luciferase reporter construct. The experiment was performed in the presence or absence of 200 nM TSA. In order to account for differences in luciferase activity between different luciferase reporter plasmids and different transactivating transcription factors, absolute luciferase activities were normalized so that the relevant luciferase activity for each different sample in the absence of RFP was 100. (g) The addition of TSA does not interfere with the interaction of E47 and RFP. An immunoprecipitation performed with an anti-flag antibody on cells from (f) shows that E47 and RFP interact in the absence or presence of TSA RFP domain (amino acids 158-513) substantially repressed reporter activity, confirming the presence of a C-terminal repression domain (Shimono et al., 2000) , whereas more modest repression was observed with an N-terminal fragment (amino acids 1-158), which may indicate the presence of a weaker N-terminal repression domain (Figure 5e ). RFP-mediated repression of E47, MyoD and mASH-1 was completely relieved by the addition of the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) (Figure 5f ). The addition of TSA did not interfere with the interaction between RFP and bHLH proteins, as E47 and RFP co-immunoprecipitated in the presence of TSA (Figure 5g ). Taken together, these results are consistent with a model in which RFP inhibits transactivation mediated by bHLH proteins by recruiting HDACs to bHLH target genes.
Discussion
Our studies show that RFP, a member of the RBCC (also called TRIM) family of proteins (reviewed in Reymond et al., 2001) , can interact with both class I (E2A) and class II bHLH proteins (SCL, mASH1, MyoD). The interaction between RFP and SCL requires the B-box and first coiled-coil domain of RFP together with the bHLH domain of SCL. RFP homo-dimerizes via its coiled-coil region, and the B-box (a cysteine-and histidine-rich domain that contains a zinc-binding site) is thought to be necessary to stabilize the interaction, possibly by maintaining the correct orientation of the coiled coils (Cao et al., 1997) . bHLH proteins are known to homo-and hetero-dimerize via their HLH domain whereas the adjacent basic domain mediates DNA binding (Murre et al., 1989) .
Our results show for the first time that RFP is able to interact with members of four different bHLH protein subfamilies, but not with GATA-1 or PU.1. In addition, RFP was able to repress trascriptional activation by the bHLH proteins, but not by members of several other transcription factor families. It seems unlikely that RFP will prove able to interact effectively with all bHLH proteins and future studies will be needed to define the range of bHLH proteins that can be repressed by RFP. The stoichiometry of the RFP/bHLH interaction also remains obscure. In particular, since MyoD, mASH-1 and SCL all form heterodimers with the ubiquitously expressed products of the E2A gene, it is not clear whether repression by RFP requires interaction with both components of a given bHLH dimer or whether interaction with a single E47 protein is sufficient.
A number of mechanisms are known to negatively regulate the function of bHLH proteins. The Id family of HLH factors function by binding and sequestering E proteins, thus preventing heterodimerization of the latter with class II bHLH factors (for a recent review see Yokota and Mori, 2002) . Non-bHLH proteins can also repress the function of bHLH proteins. For example, transcriptional activation by bHLH factors can be inhibited by their direct interaction with corepressor proteins, such as N-CoR, with the consequent repression of target genes (Bailey et al., 1999) . Finally, the function of bHLH proteins can be regulated by a number of post-translational modifications, including phosphorylation (Song et al., 1998) , acetylation and ubiquitination (Kho et al., 1997) .
Our results suggest that RFP acts as a novel nonbHLH repressor of bHLH protein function. The activity of a tethered MyoD-E47 construct, which is not inhibited by Id proteins (Neuhold and Wold, 1993) , was repressed by RFP, suggesting that RFP does not act by sequestering E2A proteins in an Id-like manner. In addition, RFP did not prevent bHLH proteins from binding DNA. Several bHLH proteins are degraded by the ubiquitin-proteasome pathway (Kho et al., 1997) , and a number of RING-finger proteins function as E3 ubiquitin ligases (Jackson et al., 2000) . However, the observation that steady-state levels of E47 and SCL were not reduced by RFP argues against this mechanism as well.
Instead, our data suggest a model in which RFP represses the target genes of bHLH proteins by recruiting other inhibitory proteins. RFP contains a repression domain (this article, Shimono et al., 2000) , and repression by RFP is sensitive to TSA, suggesting that RFP may recruit one or more HDAC proteins. Consistent with this concept, the related TRIM protein PML has been shown to inhibit transcription by recruiting corepressor molecules and HDACs (Wu et al., 2001) . In a recent report (Shimono et al., 2003) , RFP was shown to colocalize and associate with Mi-2 and with HDAC-1, consistent with a role for RFP in recruiting transcriptional repressor complexes. It may also be relevant that RFP binds to members of the Polycomb group of proteins (Shimono et al., 2000) , which have been implicated in the negative regulation of transcription and the formation of repressive chromatin structures (Gould, 1997) .
Negative regulation of class I bHLH proteins has been associated with tumour development. Mice lacking a functional E2A gene develop T-cell tumours (Yan et al., 1997) , whereas ectopic expression of E12 or E47 promotes regression of E2A-deficient lymphoma (Engel and Murre, 1999) . Recent data demonstrate that the leukaemogenic potential of AML-1-ETO (Zhang et al., 2004 ) is linked to the ability of these proteins to inhibit transcriptional activation by E proteins. Our results show that RFP can bind to and repress E47, and therefore raise the possibility that overexpression of an intact RFP protein may be tumorigenic. To our knowledge, no one has looked for RFP overexpression as a possible cause for loss of E2A function in lymphomas.
Taken together, our data show that RFP interacts with and represses transcriptional activation by a number of bHLH proteins. These results reveal a previously unrecognized molecular link between the bHLH and TRIM protein families, and are likely to be important for understanding the role of both families in normal and malignant cells.
Yeast two-hybrid analysis
To identify partner proteins for SCL, pYTH9-SCL was transformed into yeast strain Y190 (BD Biosciences Clontech, Palo Alto, CA, USA). Subsequently, a single clone expressing the fusion protein was transformed with a cDNA library expressing fusion proteins between the GAL4AD and embryonic day 10.5 (E10.5) murine cDNAs (a gift from Dr EN Olson, Southwestern Medical Center, Dallas, TX, USA). The transformants containing the two interacting hybrids were selected by growth on SC-Trp-Leu-His plates plus 25 mM 3-aminotriazole (3-AT), and b-galactosidase activity (filter lift assay). Following cotransformation of pGAL4BDCam-SCL together with a series of GAL4AD-RFP deletion constructs into yeast strain YRG-2 (Stratagene, La Jolla, CA, USA), an identical protocol was used to delineate the region of RFP that interacts with SCL. Expression of the fusion proteins was detected using GAL4AD and GAL4BD monoclonal antibodies (BD Biosciences Clontech, Palo Alto, CA, USA).
In vitro translation and GST pulldown assay 35 S labelled in vitro translated proteins were made using the TnT Coupled Reticulocyte Lysate system (Promega, Madison, WI, USA). To generate recombinant GST-RFP, pGEX4T-RFP was transformed into BL21DE3plysS Escherechia coli (Invitrogen Corp., Carlsbad, CA, USA). The recombinant protein was solubilized and refolded using the Protein Refolding Kit (Novagen Inc., Madison, WI, USA). GST-SCL fusion proteins were generated in a similar manner but no solubilization was necessary. GST pulldown assays were performed as described (Kerr et al., 1993) .
Transfections and luciferase assays 10 7 416B, Wehi 3BD þ or BW5147 cells were electroporated with 5 mg of each expression construct used, 5 mg of the corresponding reporter plasmid, 5 mg of the LacZ expression plasmid pEFBOS-LacZ with or without 15 mg of pMLV-LINK-mycRFP. Measurement of LacZ activity was used to correct for variation of transfection efficiency. 10 7 COS-7 or 10 6 293T cells were transfected using the Calcium Phosphate Profection kit (Promega Corp., Madison, WI, USA). 293T cells were transfected with 0.7 mg pE6pXp2, 0.7 mg pcDNA-PAN1, 1.3 mg pEFBOS-mycSCL and 4 or 8 mg pSG5-flagRFP or pSG-flagRFPdBC as indicated. COS-7 cells were tranfected with 3 mg of pEFBOS-mycSCL and/or 15 mg of pSG5-flagRFP as indicated. Transfections were performed in triplicate and the data presented are the mean of three independent experiments. In all, 200 nM TSA (Sigma-Aldrich Corp., St Louis, MO, USA) was added to the culture medium following transfection where indicated. Luciferase assays were performed as previously described (Bockamp et al., 1995) .
Immunoprecipitation and immunoblotting
Immune complexes were precipitated using 1.5 ml of anti-FLAG M2 antibody (Sigma-Aldrich Corp., St Louis, MO, USA) and 50 ml of protein G-agarose (Roche Diagnostics Corp., Indianapolis, IN, USA). Western detection was performed using anti-FLAG M2 and anti-myc 9E10 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. In all, 10-20% of cell lysate from each transfection was used per immunoprecipitation. Immunoprecipitation of endogenous proteins was performed in essentially the same way from the lysate of 2-5 Â 10 6 416B cells using either 3 ml of sheep anti-SCL antibody (Sinclair et al., 2002) or preimmune serum. RFP was detected with rabbit anti-RFP antisera (a gift from Dr LD Etkin, Texas University, TX, USA).
